| Tap a line for its trend | Last 12Mto Sep 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22Mar 2022 | FY21 and earlierAlpha Plus |
|---|
| 31.61× | 31.61× | 35.21× | 37.31× | 44.41× | FY21 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.42× | 1.62× | 1.26× | 1.68× | 1.15× | ||
| 0.92× | 0.92× | 0.91× | 1.10× | 0.92× | ||
| 0.72× | 0.72× | 1.83× | 1.08× | 0.45× | ||
| 0.58× | 0.58× | 1.47× | 0.81× | 0.34× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY22 31/03/2022 | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 44.41 | 37.31 | 35.21 | 31.61 | 31.61 | |
| Working Capital Turnover | 1.15 | 1.68 | 1.26 | 1.62 | 1.42 | |
| Asset Turnover | 0.92 | 1.10 | 0.91 | 0.92 | 0.92 | |
| Cash Conversion (CFO/Net Income) | 0.45 | 1.08 | 1.83 | 0.72 | 0.72 | |
| CFO/EBITDA | 0.34 | 0.81 | 1.47 | 0.58 | 0.58 |